摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethyl-N-(3-methylphenyl)formamide | 15296-55-6

中文名称
——
中文别名
——
英文名称
N-ethyl-N-(3-methylphenyl)formamide
英文别名
N-Ethyl-N-formyl-m-toluidin;formic acid-(N-ethyl-m-toluidide);Ameisensaeure-(N-aethyl-m-toluidid)
N-ethyl-N-(3-methylphenyl)formamide化学式
CAS
15296-55-6
化学式
C10H13NO
mdl
——
分子量
163.219
InChiKey
OBBYLRPECZCYHC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Catalyst-free N-formylation of amines using BH<sub>3</sub>NH<sub>3</sub> and CO<sub>2</sub> under mild conditions
    作者:Tian-Xiang Zhao、Gao-Wen Zhai、Jian Liang、Ping Li、Xing-Bang Hu、You-Ting Wu
    DOI:10.1039/c7cc03860g
    日期:——
    The catalyst-free N-formylation of amines using CO2 as the C1 source and BH3NH3 as the reductant has been developed for the first time. The corresponding formylated products of both primary and secondary amines are obtained in good to excellent yields (up to 96% of isolated yield) under mild conditions.
    首次开发了使用CO 2作为C 1源和BH 3 NH 3作为还原剂的胺的无催化剂N-甲酰化。在温和条件下,伯胺和仲胺的相应甲酰化产物均以良好至极佳的收率(高达分离收率的96%)获得。
  • Biomass-derived N-doped porous carbon: an efficient metal-free catalyst for methylation of amines with CO<sub>2</sub>
    作者:Feiying Tang、Liqiang Wang、You-Nian Liu
    DOI:10.1039/c9gc03277k
    日期:——
    Developing green, efficient, and low-cost catalysts for methylation of N–H by using CO2 as the C1 resource is highly desired yet remains a significant challenge. Herein, N-doped porous carbons (NPCs) were designed, synthesized, and proved to be an excellent metal-free catalyst for CO2-participated methylation conversion. NPCs were prepared via the pyrolysis of a mixture of tannic acid and urea. Both
    迫切需要通过使用CO 2作为C1资源开发绿色,高效且低成本的N-H甲基化催化剂,但仍然是一个巨大的挑战。本文中,设计,合成了N掺杂的多孔碳(NPC),并证明它是用于CO 2参与的甲基化转化的极佳的无属催化剂。NPC通过单宁酸尿素混合物的热解制备。理论计算和实验均表明,NPC中的N物种,特别是吡啶二氮和吡咯N可以作为Lewis的碱性位点,攻击CO 2以削弱C O键并降低分子转化障碍,从而促进N–H的甲基化反应。产生例如N,N-二甲基苯胺。此外,独特的多孔结构可以丰富CO 2并加速传质,协同促进CO 2的转化。优化的NPC (1/5)催化剂,整合的多孔结构和强路易斯碱度,表现出对CO优异的催化活性2温和的条件下基甲基化反应(1巴CO 2,75℃)。我们的工作首次证明了通过利用CO 2作为C1资源,使用NPC催化氨基化合物的甲基化以生产N,N-二甲基胺的可行性。
  • In Situ‐Generated Cu <sup>I</sup> Catalytic System for Oxidative <i>N</i> ‐Formylation of N‐Heterocycles and Acyclic Amines with Methanol
    作者:Yujing Zhang、Xingchao Dai、Jixue Wang、Junxi Liang、Jabor Rabeah、Xia Tian、Xiaoqiang Yao、Yanbin Wang、Shaofeng Pang
    DOI:10.1002/cssc.202202104
    日期:2023.2.8
    AbstractThe development of a sustainable and simple catalytic system for N‐formylation of N‐heterocycles with methanol by direct coupling remains a challenge, owing to many competing side reactions, given the sensitivity of N‐heterocycles to many catalytic oxidation or dehydrogenation systems. This work concerns the development of an in situ‐generated CuI catalytic system for oxidative N‐formylation of N‐heterocycles with methanol that is based on the case study of a more typical 1,2,3,4‐tetrahydroquinoline as substrate. Aside from N‐heterocycles, some acyclic amines are also transformed into the corresponding N‐formamides in moderate yields. Furthermore, a probable reaction mechanism and reaction pathway are proposed and extension of work based on some findings leads to a demonstration that the formed ⋅O2 and ⋅OOH radicals in the catalytic system is related to the formation of undesired tar‐like products.
  • US3960844A
    申请人:——
    公开号:US3960844A
    公开(公告)日:1976-06-01
  • [EN] PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS<br/>[FR] DERIVES DE PYRROLE EN TANT QU'AGENTS PHARMACEUTIQUES
    申请人:EXELIXIS INC
    公开号:WO2006012642A2
    公开(公告)日:2006-02-02
    Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫